English | Español
Patient Daily | Jul 9, 2025

FDA approves Longeveron's Phase 2 study for pediatric dilated cardiomyopathy treatment
Patient Daily | Jul 8, 2025

Clinical assistant professor at Stanford: ‘Musical background is associated with better performance of fundamental surgical skills'
+ Pharmaceuticals
Patient Daily | Jul 8, 2025

American Lung Association launches COPD support campaign targeting rural communities
+ Pharmaceuticals
Patient Daily | Jul 8, 2025

Stroke survivors find hope with support from UTHealth Houston
+ Pharmaceuticals
Patient Daily | Jul 8, 2025

Psychedelic mushrooms' compound shows potential antiaging effects
+ Pharmaceuticals
Patient Daily | Jul 8, 2025

American Lung Association releases educational series with Memorial Healthcare System
+ Pharmaceuticals
Patient Daily | Jul 3, 2025

American Lung Association criticizes reconciliation bill over health care cuts
+ Pharmaceuticals
Patient Daily | Jul 2, 2025

Research reveals genetic shifts behind Barrett's esophagus

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation